TTK Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of TTK Antibodies for research in cell cycle regulation and mitotic processes. TTK Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TTK, also known as Mps1, is a crucial protein kinase that plays a significant role in the spindle assembly checkpoint, ensuring proper chromosome segregation during cell division. TTK dysregulation has been implicated in various cancers, making it a vital target for therapeutic intervention and biomarker discovery. Understanding TTK function is essential for elucidating the mechanisms of tumorigenesis and developing effective cancer treatments. Researchers worldwide rely on TTK monoclonal antibodies to advance their studies in cell cycle regulation. Current investigations focus on TTK's role in cancer development and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies for TTK continue to support breakthrough discoveries in cancer research and cell biology.